Correction to: Oncogenesis https://doi.org/10.1038/s41389-020-00274-y published online 10 October 2020
Following the publication of this article an error was noted in figure assembly for Figure 2E, where an image from the control group had been mistakenly included to represent EV treatment.
The correct figure showing EV treatment is presented below.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lopatina, T., Grange, C., Cavallari, C. et al. Correction: Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming. Oncogenesis 12, 38 (2023). https://doi.org/10.1038/s41389-023-00483-1
Published:
DOI: https://doi.org/10.1038/s41389-023-00483-1
